John R Fischer

A deep dive into Kinderhook Industries’ entry into the hospice care segment; private equity interest in the oncology sector; a look at Align Capital Partners’ investment in a mobile diagnostic imaging service provider; Baker Donelson’s Toni Peck on why PE dealmakers should pay attention to academic medical centers.

AEA Investors, Bridgepoint and Kohlberg are among the PE firms investing in assets in the oncology sector.

'The fragmented industry has started to get consolidated amongst the larger players, and Enhabit is the largest independent remaining,' says Kinderhook Industries' Matt Bubis.

Exploring private equity interest in the pain management sector; a look at the completed merger of two medtech manufacturers into an orthopedics-focused platform and backed by Charlesbank Capital Partners and Nordic Capital.

Charterhouse Capital, Iron Path and Revelar Capital are among the PE firms investing in platforms and add-ons for pain management.

Discussing the platform and M&A opportunities firms see in the pharmaceutical and life science sector; a look at Eir Partners’ investment in a life sciences data analytics company; insights from a conference hosted by Houlihan Lokey on what’s needed to leverage AI to help businesses thrive in the era of disintermediation.

Blackstone, Audax, Bridgepoint and Baird are among the PE firms targeting add-ons for pharmaceutical and life science consultancy platforms.

Goldman Sachs, Avesi Partners, Grovecourt Capital and QC Capital are among the PE firms investing in telehealth companies.

With sizable and stable EBITDA multiples, ophthalmology assets have become highly sought after by private equity.

Goldman Sachs, Gryphon Investors, MidEuropa and Olympus are among the PE firms eying platform investments and consolidation in eye care.